• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Characterising ‘Spree Bar: an examination of the popularity, marketing and composition of a vaping device with a nicotine analogue across multiple data streams

Background

Spree Bar, a line of e-cigarette devices introduced in 2023, leverages 6-methylnicotine (6-MN) as its primary ingredient and is available in nine flavours, each represented by artificial intelligence (AI)-generated avatars.

Aims

To characterise the popularity (via social media analysis and survey data), content (nicotine, nicotine analogues, common flavouring chemicals) and marketing strategy (product avatars and flavour descriptions created by the company on its website and Instagram) of Spree Bar.

Results

Publicly available secondary data (Population Assessment of Tobacco and Health, National Youth Tobacco Survey (NYTS), International Tobacco Control (ITC) Youth survey) have not captured any reported use of Spree Bar. Social media observations revealed little public discussion of Spree Bar, aside from activity surrounding news stories. Chemical analysis confirmed that Spree Bar did not contain nicotine and that the levels of 6-MN were significantly lower than claimed (approximately 0.3% vs 5%). Wilkinson Sword (WS)-23, a synthetic coolant, was present in all varieties, regardless of nominal flavour. Linguistic analysis of Spree Bar promotional text from their novel marketing strategy indicates very little difference in language used across avatars or nominal flavours.

Conclusions

There is limited evidence of widespread uptake of Spree Bar to date. However, its marketing approach and striking mislabeling and coolant ubiquity underscore the need for regulatory vigilance.

Read the full article ›

Posted in: Journal Article Abstracts on 02/11/2026 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice